NL-OMON41388招募中不适用
TApering strategies in Rheumatoid Arthritis remission induced by anti-TNF&classic DMARDs. Should we taper the classic DMARD or anti-TNF first? - TARA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 355
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •RA patients, aged >17 years, treated with DMARDs&etanercept,adalimumab,certolizumab or golimumab, DAS <= 2.4 and swollen joint count <=1 for two consecutive time points (3 months)
排除标准
- •Not being able to understand, speak and write in Dutch.
- •Being diagnosed with a psychiatric or personality disorder.
研究者
相似试验
已完成
不适用
Treatment strategies for Rheumatoid Arthritis (BeSt - BehandelStrategieën in Reumatoïde Artritis)Musculoskeletal DiseasesArthropathiesRheumatoid arthritisISRCTN32675862eiden University Medical Centre (LUMC) (Netherlands)508
已完成
不适用
BeSt, BehandelStrategieën in Reumatoïde Artritis.NL-OMON24149Dutch College of Health Insurance Companies508
已完成
不适用
Active management of rheumatoid arthritis (RA)ISRCTN78142229Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)100
招募中
不适用
TrEatment Targets in Rheumatoid Arthritis: a randomized multi-centre, treat to target strategy trial: TETRA studyjoint inflammation1000381610023213rheumatoid arthritisNL-OMON53234Sint Maartenskliniek340
已完成
不适用
Supplemental treatment of rheumatoid arthritis with natural milk antibodies against enteromicrobes and their toxinsRheumatoid ArthritisJPRN-UMIN000003128Asama Chemical Co. Ltd.,40